Written by Jamie Stowe| Wednesday, 11 March 2009| There are 0 comments
The smoking cessation drug Champix has come into some bad press recently after reports that it aggravated depression in some individuals however a new survey in the Journal of General Internal Medicine claims that people who have a medical history of depression were not more likely to experience depressive symptoms when using the drug.

The researchers led by Professor Jennifer McClure from the Group Health Centre for Health Studies conducted a randomised smoking cessation clinical trial specifically focusing on people who had a medical history of depression. It was noted that while some of them did report depressive symptoms they were no worse than those which were reported by other people who took part in the trial and who did not have a medical history of depression.
Pfizer who make the smoking cessation drug Champix recently changed the labeling on the drug to warn that it could increase neuropsychiatric symptoms especially with those people having a psychiatric history. However since the original clinical trials for Champix did not include people with psychiatric problems it cannot be conclusively confirmed that the drug contributes to the problem.
At Ukmedix News our advice is quite simple when it comes to the use of smoking cessation medication. You have to remember that with all powerful drugs there will be side effects and you should make note of them. You should inform a friend or family that you are using smoking cessation medication and if you feel depressed like with any other medication you should stop using it immediately.
You should always keep in mind that the statistical risk from Champix is minimal compared to the risk of continuing to smoke. One thing is for sure that if you continue to smoke it will put you into an early grave.
